These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 582682

  • 1. [In vitro and in vivo investigations with different nitrofurantoin formulations (author's transl)].
    Gladigau V, Gebhardt U.
    Arzneimittelforschung; 1978; 28(10):1771-8. PubMed ID: 582682
    [Abstract] [Full Text] [Related]

  • 2. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR, Chodos DJ, Phillips JP, DeSante KA, Stoll RG.
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):220-7. PubMed ID: 950266
    [Abstract] [Full Text] [Related]

  • 3. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
    Brockmeier D, von Hattingberg HM.
    Arzneimittelforschung; 1982 Apr; 32(3):248-51. PubMed ID: 6896279
    [Abstract] [Full Text] [Related]

  • 4. [In vitro and in vivo biopharmaceutical evaluation of lorazepam commercial tablets].
    Giannone I, Musumeci T, Pecora TM, Puglisi G.
    Clin Ter; 2005 Apr; 156(5):197-201. PubMed ID: 16382968
    [Abstract] [Full Text] [Related]

  • 5. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS, Chowhan Z.
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [Abstract] [Full Text] [Related]

  • 6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [Abstract] [Full Text] [Related]

  • 7. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 8. In vitro/in vivo evaluation of hydrochlorothiazide in experimental hydrochlorothiazide/triamterene combination tablets in beagle dogs.
    Ritschel WA, Turkoglu M, Lipps D, Warner A, Sakr A.
    Arzneimittelforschung; 1991 Mar; 41(3):208-11. PubMed ID: 1867656
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A, Li S, Weaver M, Shah U.
    J Control Release; 2004 May 31; 97(1):79-90. PubMed ID: 15147806
    [Abstract] [Full Text] [Related]

  • 10. In vivo/in vitro correlations of nitrofurantoin matrix tablet formulations.
    Karasulu HY, Ertan G, Köse T, Günerí T.
    Eur J Drug Metab Pharmacokinet; 1996 May 31; 21(1):27-31. PubMed ID: 8839675
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH, Kassem MA.
    Eur J Pharm Biopharm; 2008 Aug 31; 69(3):993-1003. PubMed ID: 18396390
    [Abstract] [Full Text] [Related]

  • 12. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr 31; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 13. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H, Löbenberg R.
    Eur J Pharm Sci; 2006 Sep 31; 29(1):45-52. PubMed ID: 16815694
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 31; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 15. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U, Ray KK, Gowda V, Ghosh A, Pal TK.
    J Pharm Pharmacol; 2007 Jul 31; 59(7):971-6. PubMed ID: 17637192
    [Abstract] [Full Text] [Related]

  • 16. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
    Bendas ER.
    Arch Pharm Res; 2009 Sep 31; 32(9):1317-29. PubMed ID: 19784589
    [Abstract] [Full Text] [Related]

  • 17. Pharmaceutical availability from oral dosage forms: in vitro release of nitrofurantoin from tablets and capsules.
    Senjković R, Kallay N, Vilendecić M.
    Pharmazie; 1987 Mar 31; 42(3):186-8. PubMed ID: 3602077
    [Abstract] [Full Text] [Related]

  • 18. Development of a reaction-limited model of dissolution: application to official dissolution tests experiments.
    Dokoumetzidis A, Papadopoulou V, Valsami G, Macheras P.
    Int J Pharm; 2008 May 01; 355(1-2):114-25. PubMed ID: 18206324
    [Abstract] [Full Text] [Related]

  • 19. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G, Venier A.
    Boll Chim Farm; 1973 May 01; 112(6):416-21. PubMed ID: 4767643
    [No Abstract] [Full Text] [Related]

  • 20. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N.
    Eur J Pharm Biopharm; 2008 Oct 01; 70(2):674-83. PubMed ID: 18606224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.